New drug trial hopes to tame rare genetic heart disease
NCT ID NCT07241104
First seen Nov 21, 2025 · Last updated Apr 28, 2026 · Updated 22 times
Summary
This early-stage study tests a new medicine called AZD4063 in 31 adults with a specific genetic heart condition (PLN R14del dilated cardiomyopathy). The main goal is to check if the drug is safe and how the body processes it. Participants must have a weakened heart pump and be on stable heart medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DILATED CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGAmsterdam, 1081 HV, Netherlands
-
Research Site
RECRUITINGGroningen, 9713 GZ, Netherlands
-
Research Site
RECRUITINGRotterdam, 3015 GD, Netherlands
-
Research Site
RECRUITINGUtrecht, 3584 CX, Netherlands
Conditions
Explore the condition pages connected to this study.